-TheWire.in Due to cultural reasons, India has a relatively small market for processed foods, and a number of factors afflict the food processing industry. In the light of recent farmer protests, there have been apprehensions that corpoRATes will develop a monopoly over agricultural markets, purchase large quantities of cereals at cheaper prices and sell processed products made from them at very high prices. These apprehensions do not seem very plausible in the near...

Commenting on the recently released fifth round of National Family Health Survey (NFHS-5) data for 17 states and five Union Territories (UTs) in an article published in The Indian Express (dated 6th January, 2021), Arvind Subramanian and his co-authors have stated that India has made progress on certain outcomes, including infant mortality RATe (IMR), under-five mortality RATe (U5MR) and neonatal mortality RATe (NNMR). Relying on various rounds of NFHS data,...

-The Indian Express Anganwadi workers, ASHAs, ANMs and anganwadi supervisors can work together with panchayat members to ensure that all children and mothers are covered with immunisation, antenatal care, maternity benefits and nutrition services On an MGNREGA worksite in Kolar, Karnataka, a male worker came up to me and said that men ought to be paid more than women. I asked him why. “Adhu yaavaagalu hange,” he replied: That was how it...

-The Hindu With no urban equivalent to the NREGA as yet, there must be a focus on supporting new forms of employment With the Indian economy gradually finding its feet after a historic contraction of negative 23.9% in the April-June quarter, economic commentators have busied themselves with debating the need for fiscal expansion and the viability of a “V-shaped recovery”. These debates, however, have shifted focus away from the employment question, considered...

-The Hindu They advise against Covaxin, say there is no proof of efficacy. Several experts have raised concern over the “hasty approval” granted to the COVID-19 vaccines despite the lack of adequate efficacy data. The Central Drugs Standard Control Organisation on Sunday accorded approval for restricted emergency use of the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India (SII), and the indigenously developed vaccine Covaxin of BhaRAT Biotech. “I’m completely unaware...